Skip to main content
Article
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
medRxiv
  • Alexa K Dowdell, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.
  • Kevin Matlock
  • Fred L Robinson, Providence St. Joseph Health
  • Roshanthi Weerasinghe, Providence St Joseph Health, Renton, WA.
  • Rogan Rattray, Providence St. Joseph Health
  • Marina Pukay, Providence St. Joseph Health
  • Melvin Lathara
  • Anastacia Harlan, Providence St. Joseph Health
  • Thomas R Ward, Providence St. Joseph Health
  • Mary Campbell, Providence St. Joseph Health
  • Walter Urba, Earle A. Chiles Research Institute
  • Ganapati Srinivasa
  • Carlo Bifulco, Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, OR
  • Brian D. Piening, Molecular Genomics Laboratory, Providence Portland Medical Center, Portland, OR; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Cancer Center, Portland, OR.
Document Type
Article
Publication Date
8-4-2020
Keywords
  • 2019-nCoV,
  • genomics
Abstract

The first reported case of COVID-19 in the State of Oregon occurred in late February 2020, with subsequent outbreaks occurring in the populous Portland metro area but also with significant outbreaks in less-populous and rural areas. Here we report viral sequences from 188 patients across the hospitals and associated clinics in the Providence Health System in the State of Oregon dating back to the early days of the outbreak. We show a significant shift in dominant clade lineages over time in Oregon, with the rapid emergence and dominance of Spike D614G-positive variants. We also highlight significant diversity in SARS-CoV-2 sequences in Oregon, including a large number of rare mutations, indicative that these genomes could be utilized for outbreak tracing. Lastly, we show that SARS-CoV-2 genomic information may offer additional utility in combination with clinical covariates in the prediction of acute disease phenotypes.

Specialty
Earle A. Chiles Research Institute
Specialty
Infectious Diseases
Comments

This article is a preprint and has not been certified by peer review. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Citation Information
Alexa K Dowdell, Kevin Matlock, Fred L Robinson, Roshanthi Weerasinghe, et al.. "Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon" medRxiv (2020)
Available at: http://works.bepress.com/carlo-bifulco/10/